-
Divergent Biologic Price Archetypes: Year-on-Year List Price Evolution Pre- and Post-Biosimilar Entry in the US, Europe, and Japan
Sep 9, 2025, 16:22 PM -
Cost-Consequence of Incorporating Single-Operator Direct Visualization Cholangioscopy in the Diagnosis of Indeterminate Biliary Strictures in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ribociclib With Endocrine Therapy for Treatment With Premenopausal Women With HR Positive HER2 Negative Early Breast Cancer in the UK
Sep 9, 2025, 16:22 PM -
Strengths and Limitations of AI-Assisted Abstract Screening to Identify Patient-Reported Outcome Instruments: A Comparison of Two AI-Assisted Platforms and Traditional Methods
Sep 9, 2025, 16:22 PM -
Provisional Listing of Digital Healthcare Applications Digas Improves Patients' Access to Healthcare in Germany
Sep 9, 2025, 16:22 PM -
Burden of Illness Among Patients With Transfusion Dependent Beta-Thalassemia in Spain: A Registry-Based Study
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review and Meta-Analysis Comparing Robotic-Assisted Mitral Valve Repair Using the Da Vinci Surgical System to Open Mitral Valve Repair
Sep 9, 2025, 16:22 PM -
Patient Involvement in Health Technology Assessment: A Global Review of Practices, Purposes, and Pathways
Sep 9, 2025, 16:22 PM -
Building Risk-Sharing Agreements in Chile: Feasibility and Policy Options
Sep 9, 2025, 16:22 PM -
Why Current HTA Frameworks Fall Short for Anti-Cancer Combination Therapies: Toward Equitable Value Attribution and Policy Reform
Sep 9, 2025, 16:22 PM -
Value Framework to Support Payer Decisions in Hemophilia in Türkiye
Sep 9, 2025, 16:22 PM -
Treatment Preferences in Adults With Chronic Spontaneous Urticaria in Italy: Insights From the CHOICE-CSU 2 Study
Sep 9, 2025, 16:22 PM -
Using Directed Acyclic Graphs in Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison: Systematic Review and Methodological Insights
Sep 9, 2025, 16:22 PM -
Triangulation Method to Detect Meaningful Deterioration in Patient's Autonomy Using the New Multiple Sclerosis Autonomy Scale (MSAS) Questionnaire
Sep 9, 2025, 16:22 PM -
Economic Burden Utilities and Cost-Effectiveness of Perioperative Immunotherapies for Early Stage Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of First-Line Lorlatinib for ALK-Positive Advanced NSCLC in the UK
Sep 9, 2025, 16:22 PM -
Disease Management in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population
Sep 9, 2025, 16:22 PM -
NCFBE Hospitalizations Costs Across Different Healthcare Systems: Insights From England and France in 2022 Using PMSI and HES Databases
Sep 9, 2025, 16:22 PM -
Evaluating Treatment Benefit and Tolerability Based on Responder and Time-to-Event Analysis of Patient-Reported Outcomes in Cancer Clinical Trials: A Scoping Review
Sep 9, 2025, 16:22 PM -
Mapping the Use of Capability Measures ICECAP-A and O in Economic Evaluations
Sep 9, 2025, 16:22 PM
